Clinical Trial

Early Methylene Blue in the Microhemodynamics of Septic Patients

Recruiting Phase 2/3
View on ClinicalTrials.gov →
Summary
The aim of the study is to evaluate the viability and feasibility of its protocol in order to conduct a larger clinical trial to assess whether methylene blue can improve patient-centered clinical outcomes such as mortality or length of hospital stay in septic shock patients.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-12-02; most recent amendment 2026-03-24.
Status change: Not Yet Recruiting → Recruiting 2026-01-07
Trial Details
NCT Number NCT07264543
Lead Sponsor Centro de Estudos e Pesquisa em Emergencias Medicas e Terapia Intensiva
Collaborators: Irmandade da Santa Casa de Misericordia de Curitiba
Conditions Septic Shock, Hypoperfusion
Enrollment 50 participants
Start Date 2026-01-09
Primary Completion 2026-11-30 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-27